CSF1R and pancreatic ductal adenocarcinoma: By targeting the colony-stimulating factor-1 receptor (CSF-1R) or CXCR2, the inhibition of TAM recruitment resulted in a STAT3-dependent decrease in CSC numbers in a mouse model of pancreatic ductal adenocarcinoma (PDAC) [55].